November DTR Chart: Top States by Medicare HMO enrollment

A forecast of the year by Bill Kerr, M.D., MBA, CEO of Avalon Healthcare Solutions.

Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.

Lenacapavir has the potential to transform HIV care and prevention, but only if access is broadened, according to Jose Abrigo, Esq., HIV Project Director of the Lambda Legal Defense and Education Fund.

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.

Michael Poku, M.D., chief clinical officer of Equality Health, shared his prediction for 2025.

Mayo Clinic researchers find that stem cells with the highest Myc expression become dominant in driving lung remodeling .